Inventory Summary of IntelGenx Technologies Corp.

IntelGenx Technologies Corp.'s latest annual inventory in 2023 was 71 Thousand USD , up 14.52% from previous year.
IntelGenx Technologies Corp.'s latest quarterly inventory in 2024 Q1 was 173 Thousand USD , up 143.66% from previous quarter.
IntelGenx Technologies Corp. reported annual inventory of 62 Thousand USD in 2022, down 0.0% from previous year.
IntelGenx Technologies Corp. reported annual inventory of 62 Thousand USD in 2021, down -74.59% from previous year.
IntelGenx Technologies Corp. reported quarterly inventory of 83 Thousand USD for 2023 Q2, up 18.57% from previous quarter.
IntelGenx Technologies Corp. reported quarterly inventory of 71 Thousand USD for 2023 FY, up 14.52% from previous quarter.

Annual Inventory Chart of IntelGenx Technologies Corp. (2023 - 2003)

Historical Annual Inventory of IntelGenx Technologies Corp. (2023 - 2003)

Year	Inventory	Inventory Growth
2023	71 Thousand USD	14.52%
2022	62 Thousand USD	0.0%
2021	62 Thousand USD	-74.59%
2020	244 Thousand USD	-36.13%
2019	382 Thousand USD	1.87%
2018	375 Thousand USD	37499900.0%
2017	1.00 USD	0.0%
2016	- USD	0.0%
2015	- USD	-100.0%
2014	1.00 USD	0.0%
2013	1.00 USD	0.0%
2012	1.00 USD	0.0%
2011	- USD	0.0%
2010	- USD	0.0%
2009	- USD	0.0%
2008	- USD	-100.0%
2007	23.44 Thousand USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	173 Thousand USD	143.66%
2023 Q2	83 Thousand USD	18.57%
2023 FY	71 Thousand USD	14.52%
2023 Q4	71 Thousand USD	-12.35%
2023 Q3	81 Thousand USD	-2.41%
2023 Q1	70 Thousand USD	12.9%
2022 Q3	80 Thousand USD	-5.88%
2022 Q4	62 Thousand USD	-22.5%
2022 Q1	88 Thousand USD	41.94%
2022 Q2	85 Thousand USD	-3.41%
2022 FY	62 Thousand USD	0.0%
2021 Q2	121 Thousand USD	0.83%
2021 Q4	62 Thousand USD	-8.82%
2021 FY	62 Thousand USD	-74.59%
2021 Q3	68 Thousand USD	-43.8%
2021 Q1	120 Thousand USD	-50.82%
2020 Q1	350 Thousand USD	-8.38%
2020 Q2	370 Thousand USD	5.71%
2020 FY	244 Thousand USD	-36.13%
2020 Q3	279 Thousand USD	-24.59%
2020 Q4	244 Thousand USD	-12.54%
2019 FY	382 Thousand USD	1.87%
2019 Q4	382 Thousand USD	-1.04%
2019 Q3	386 Thousand USD	-1.28%
2019 Q2	391 Thousand USD	2.09%
2019 Q1	383 Thousand USD	2.13%
2018 Q2	1.00 USD	0.0%
2018 Q3	- USD	-100.0%
2018 FY	375 Thousand USD	37499900.0%
2018 Q4	375 Thousand USD	0.0%
2018 Q1	- USD	-100.0%
2017 Q1	- USD	0.0%
2017 FY	1.00 USD	0.0%
2017 Q4	1.00 USD	100.0%
2017 Q3	-1.63 Million USD	0.0%
2017 Q2	- USD	0.0%
2016 FY	- USD	0.0%
2016 Q4	- USD	-100.0%
2016 Q3	1.00 USD	0.0%
2016 Q2	1.00 USD	0.0%
2016 Q1	1.00 USD	0.0%
2015 Q1	- USD	-100.0%
2015 Q3	- USD	-100.0%
2015 FY	- USD	-100.0%
2015 Q2	1.00 USD	0.0%
2015 Q4	- USD	0.0%
2014 FY	1.00 USD	0.0%
2014 Q3	1.00 USD	0.0%
2014 Q2	- USD	-100.0%
2014 Q1	1.00 USD	0.0%
2014 Q4	1.00 USD	0.0%
2013 Q1	1.00 USD	0.0%
2013 FY	1.00 USD	0.0%
2013 Q4	1.00 USD	0.0%
2013 Q3	1.00 USD	0.0%
2013 Q2	- USD	-100.0%
2012 Q1	- USD	0.0%
2012 FY	1.00 USD	0.0%
2012 Q4	1.00 USD	0.0%
2012 Q3	- USD	0.0%
2012 Q2	- USD	0.0%
2011 Q1	- USD	0.0%
2011 Q2	- USD	0.0%
2011 Q3	- USD	0.0%
2011 Q4	- USD	0.0%
2011 FY	- USD	0.0%
2010 Q1	- USD	0.0%
2010 FY	- USD	0.0%
2010 Q3	- USD	0.0%
2010 Q2	- USD	0.0%
2010 Q4	- USD	0.0%
2009 Q3	- USD	0.0%
2009 Q2	- USD	0.0%
2009 Q4	- USD	0.0%
2009 Q1	- USD	0.0%
2009 FY	- USD	0.0%
2008 Q2	- USD	0.0%
2008 Q4	- USD	0.0%
2008 Q3	- USD	0.0%
2008 Q1	- USD	-100.0%
2008 FY	- USD	-100.0%
2007 Q2	- USD	0.0%
2007 Q4	23.44 Thousand USD	0.0%
2007 Q1	- USD	0.0%
2007 FY	23.44 Thousand USD	0.0%
2007 Q3	- USD	0.0%
2006 Q2	- USD	0.0%
2006 Q4	- USD	0.0%
2006 Q1	- USD	0.0%
2006 FY	- USD	0.0%
2006 Q3	- USD	0.0%
2005 Q2	- USD	0.0%
2005 Q3	- USD	0.0%
2005 Q4	- USD	0.0%
2005 FY	- USD	0.0%
2005 Q1	- USD	0.0%
2004 FY	- USD	0.0%
2004 Q1	- USD	0.0%
2004 Q2	- USD	0.0%
2004 Q3	- USD	0.0%
2004 Q4	- USD	0.0%
2003 FY	- USD	0.0%

Peer Inventory Comparison of IntelGenx Technologies Corp.

Name	Inventory	Inventory Difference
Burzynski Research Institute, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	94.797%
Evofem Biosciences, Inc.	1.69 Million USD	95.816%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	96.699%
Qrons Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	7938.00 USD	-794.432%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	95.437%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-589.12%
Institute of Biomedical Research Corp.	- USD	-Infinity%
SQZ Biotechnologies Company	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-7099900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Mesoblast Limited	1.00 USD	-7099900.0%
Marizyme, Inc.	24.85 Thousand USD	-185.657%
Genus plc	89.4 Million USD	99.921%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	99.875%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-214.521%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	175.043%
Nymox Pharmaceutical Corporation	16 Thousand USD	-343.75%
ContraFect Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
IMV Inc.	2.00 USD	-3549900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
ONE Bio Corp.	4.5 Million USD	98.424%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	90.944%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	95.85%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	20.57 Million USD	99.655%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	12 Thousand USD	-491.667%
Curative Biotechnology, Inc.	-115.62 Thousand USD	161.405%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	21.471%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	99.999%
Wesana Health Holdings Inc.	1.00 USD	-7099900.0%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	97.005%
Nuo Therapeutics, Inc.	209.58 Thousand USD	66.124%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	310.55 Million USD	99.977%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-516.319%
Zenith Capital Corp.	3.00 USD	-2366566.667%
Genscript Biotech Corporation	53.33 Million USD	99.867%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-42.0%
WPD Pharmaceuticals Inc.	0.25 USD	-28399900.0%
Cotinga Pharmaceuticals Inc.	0.98 USD	-7244797.959%
Kadimastem Ltd	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	99.447%
BioStem Technologies, Inc.	658.67 Thousand USD	89.221%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	443.476%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	815254.994%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	94.378%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	99.527%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-7099900.0%
Gelesis Holdings, Inc.	6.86 Million USD	98.966%
CSL Limited	5.96 Billion USD	99.999%
Cellectis S.A.	1.00 USD	-7099900.0%

Global Stocks Search

IntelGenx Technologies Corp. (IGXT)

Inventory Summary of IntelGenx Technologies Corp.

Annual Inventory Chart of IntelGenx Technologies Corp. (2023 - 2003)

Historical Annual Inventory of IntelGenx Technologies Corp. (2023 - 2003)

Peer Inventory Comparison of IntelGenx Technologies Corp.